soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). ⁣ ⁣ #ACC25 #Cardiology #ClinicalTrials #NEJM Oral Semaglutide and Cardiovascular Outcomes

In early 2019 Novo Nordisk filed with the US FDA to obtain approval for an oral version (Rybelsus) of its injectable drug semaglutide (Ozempic) and it was approved in September of 2019

There are various kinds of congenital and acquired melanocytic naevi (American spelling 'nevi')

If you experience nausea, fatigue, or GI issues, you won't know which compound is responsible

Curcumin modulates critical pathways such as NF-B and downregulates IL-6 and TNF- signaling, leading to improvements in both glucose metabolism and depressive symptoms (Sarmiento-Ortega et al., 2025

If you experience any side effects while using Zepbound, a licensed medical professional can assist you in managing these changes to ensure your safety

Ozempic is not just a celebrity buzzword